603231 索宝蛋白
已收盘 04-27 15:00:00
资讯
新帖
简况
每周股票复盘:索宝蛋白(603231)2025年净利增56.56%
证券之星 · 04-26 05:39
每周股票复盘:索宝蛋白(603231)2025年净利增56.56%
索宝蛋白(603231)披露2025年度募集资金存放与实际使用情况,4月24日股价上涨0.39%
证券之星 · 04-24
索宝蛋白(603231)披露2025年度募集资金存放与实际使用情况,4月24日股价上涨0.39%
图解索宝蛋白年报:第四季度单季净利润同比增长45.86%
证券之星 · 04-24
图解索宝蛋白年报:第四季度单季净利润同比增长45.86%
每周股票复盘:索宝蛋白(603231)股东减持144.52万股,占总股本0.7548%
证券之星 · 04-19
每周股票复盘:索宝蛋白(603231)股东减持144.52万股,占总股本0.7548%
4月13日索宝蛋白发布公告,股东减持144.52万股
证券之星 · 04-13
4月13日索宝蛋白发布公告,股东减持144.52万股
索宝蛋白(603231.SH):公司与ADM没有直接的业务合作
中金财经 · 03-25
索宝蛋白(603231.SH):公司与ADM没有直接的业务合作
索宝蛋白(603231.SH):目前在中东市场的销售占比极低
中金财经 · 03-25
索宝蛋白(603231.SH):目前在中东市场的销售占比极低
股市必读:索宝蛋白(603231)3月23日收盘跌6.46%,主力净流出216.71万元
证券之星 · 03-24
股市必读:索宝蛋白(603231)3月23日收盘跌6.46%,主力净流出216.71万元
索宝蛋白(603231)披露股东减持股份计划公告,3月16日股价下跌0.21%
证券之星 · 03-16
索宝蛋白(603231)披露股东减持股份计划公告,3月16日股价下跌0.21%
每周股票复盘:索宝蛋白(603231)股东拟减持不超0.75%股份
证券之星 · 03-15
每周股票复盘:索宝蛋白(603231)股东拟减持不超0.75%股份
索宝蛋白最新公告:股东上海邦吉拟减持不超0.75%股份
证券之星 · 03-13
索宝蛋白最新公告:股东上海邦吉拟减持不超0.75%股份
每周股票复盘:索宝蛋白(603231)现12笔大宗交易机构净买入2522.34万
证券之星 · 03-08
每周股票复盘:索宝蛋白(603231)现12笔大宗交易机构净买入2522.34万
3月3日索宝蛋白发布公告,股东减持245.8万股
证券之星 · 03-03
3月3日索宝蛋白发布公告,股东减持245.8万股
股市必读:2月27日索宝蛋白现6笔大宗交易 机构净买入663万元
证券之星 · 03-02
股市必读:2月27日索宝蛋白现6笔大宗交易 机构净买入663万元
每周股票复盘:索宝蛋白(603231)现大宗交易机构净买入
证券之星 · 03-01
每周股票复盘:索宝蛋白(603231)现大宗交易机构净买入
2月26日索宝蛋白发布公告,股东减持262.44万股
证券之星 · 02-26
2月26日索宝蛋白发布公告,股东减持262.44万股
2月25日索宝蛋白现5笔大宗交易 机构净买入1085.48万元
证券之星 · 02-25
2月25日索宝蛋白现5笔大宗交易 机构净买入1085.48万元
索宝蛋白跌5.22% 2023年上市超募4.2亿元
中金财经 · 02-12
索宝蛋白跌5.22% 2023年上市超募4.2亿元
每周股票复盘:索宝蛋白(603231)每股派现0.07元(含税)
证券之星 · 02-08
每周股票复盘:索宝蛋白(603231)每股派现0.07元(含税)
索宝蛋白(603231.SH)2025年前三季度权益分派:每股派利0.07元
中金财经 · 02-05
索宝蛋白(603231.SH)2025年前三季度权益分派:每股派利0.07元
加载更多
公司概况
公司名称:
宁波索宝蛋白科技股份有限公司
所属行业:
农副食品加工业
上市日期:
2023-12-15
主营业务:
宁波索宝蛋白科技股份有限公司的主营业务是大豆蛋白系列产品的研发、生产和销售。公司的主要产品是大豆分离蛋白、大豆浓缩蛋白、组织化蛋白、非转基因大豆油、大豆膳食纤维。2024年,子公司生物科技被国家工信部认定为国家级绿色工厂,实现企业绿色产业化健康发展。2025年,生物科技荣获“山东省农业行业领军企业”、“山东省制造业单项冠军企业”“高新技术企业”等荣誉,非转基因大豆油获得“鲁链优品”认定。
发行价格:
21.29
{"stockData":{"symbol":"603231","market":"SH","secType":"STK","nameCN":"索宝蛋白","latestPrice":17.83,"timestamp":1777273201000,"preClose":17.83,"halted":0,"volume":2075700,"delay":0,"changeRate":0,"floatShares":106000000,"shares":191000000,"eps":1.3489,"marketStatus":"已收盘","change":0,"latestTime":"04-27 15:00:00","open":17.8,"high":17.87,"low":17.5,"amount":36750200,"amplitude":0.0208,"askPrice":17.83,"askSize":17,"bidPrice":17.82,"bidSize":70,"shortable":0,"etf":0,"ttmEps":1.3489,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777339800000},"marketStatusCode":5,"adr":0,"adjPreClose":17.83,"symbolType":"stock","openAndCloseTimeList":[[1777253400000,1777260600000],[1777266000000,1777273200000]],"highLimit":19.61,"lowLimit":16.05,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":191459105,"isCdr":false,"pbRate":1.7,"roa":"--","peRate":13.218178,"roe":"9.82%","epsLYR":0.99,"committee":-0.409574,"marketValue":3414000000,"turnoverRate":0.0195,"status":2,"floatMarketCap":1895000000},"requestUrl":"/m/hq/s/603231","defaultTab":"news","newsList":[{"id":"2630020638","title":"每周股票复盘:索宝蛋白(603231)2025年净利增56.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630020638","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630020638?lang=zh_cn&edition=full","pubTime":"2026-04-26 05:39","pubTimestamp":1777153151,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,索宝蛋白报收于17.83元,较上周的17.78元上涨0.28%。业绩披露要点财务报告索宝蛋白2025年主营收入17.48亿元,同比上升12.39%;归母净利润1.9亿元,同比上升56.56%;扣非净利润1.81亿元,同比上升65.54%。东吴证券股份有限公司关于宁波索宝蛋白科技股份有限公司2025年度募集资金存放与实际使用情况的核查意见截至2025年12月31日,募集资金期末余额为2,504.43万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600002402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629817783","title":"索宝蛋白(603231)披露2025年度募集资金存放与实际使用情况,4月24日股价上涨0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629817783","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629817783?lang=zh_cn&edition=full","pubTime":"2026-04-24 18:18","pubTimestamp":1777025897,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,索宝蛋白报收于17.83元,较前一交易日上涨0.39%,最新总市值为34.14亿元。该股当日开盘17.75元,最高17.88元,最低17.48元,成交额达4562.9万元,换手率为2.43%。公司于近日披露《东吴证券股份有限公司关于宁波索宝蛋白科技股份有限公司2025年度募集资金存放与实际使用情况的核查意见》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400054994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231","BK0238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629685111","title":"图解索宝蛋白年报:第四季度单季净利润同比增长45.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629685111","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629685111?lang=zh_cn&edition=full","pubTime":"2026-04-24 01:07","pubTimestamp":1776964073,"startTime":"0","endTime":"0","summary":"证券之星消息,索宝蛋白2025年年报显示,当年度公司主营收入17.48亿元,同比上升12.39%;归母净利润1.9亿元,同比上升56.56%;扣非净利润1.81亿元,同比上升65.54%;其中2025年第四季度,公司单季度主营收入5.08亿元,同比上升26.86%;单季度归母净利润4302.85万元,同比上升45.86%;单季度扣非净利润3959.36万元,同比上升40.11%;负债率11.57%,投资收益283.84万元,财务费用-314.21万元,毛利率16.68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400002798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628751158","title":"每周股票复盘:索宝蛋白(603231)股东减持144.52万股,占总股本0.7548%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628751158","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628751158?lang=zh_cn&edition=full","pubTime":"2026-04-19 03:57","pubTimestamp":1776542227,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘,索宝蛋白报收于17.78元,较上周的17.46元上涨1.83%。本周关注点股本股东变化:股东邦吉(上海)管理有限公司减持144.52万股,占公司总股本0.7548%。股本股东变化股东增减持4月13日索宝蛋白发布公告《索宝蛋白:减持股份结果公告》,其股东邦吉(上海)管理有限公司于2026年4月7日至2026年4月10日间合计减持144.52万股,占公司目前总股本的0.7548%,变动期间该股股价上涨3.13%,截止4月10日收盘报17.46元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001345.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627431651","title":"4月13日索宝蛋白发布公告,股东减持144.52万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627431651","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627431651?lang=zh_cn&edition=full","pubTime":"2026-04-13 18:01","pubTimestamp":1776074490,"startTime":"0","endTime":"0","summary":"证券之星消息,4月13日索宝蛋白发布公告《索宝蛋白:减持股份结果公告》,其股东邦吉(上海)管理有限公司于2026年4月7日至2026年4月10日间合计减持144.52万股,占公司目前总股本的0.7548%,变动期间该股股价上涨3.13%,截止4月10日收盘报17.46元。股东增减持详情见下表:根据索宝蛋白2025年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041300025748.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622241990","title":"索宝蛋白(603231.SH):公司与ADM没有直接的业务合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2622241990","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622241990?lang=zh_cn&edition=full","pubTime":"2026-03-25 17:57","pubTimestamp":1774432622,"startTime":"0","endTime":"0","summary":"格隆汇3月25日丨索宝蛋白(603231.SH)在投资者互动平台表示,公司与ADM没有直接的业务合作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260325/32097878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4588","BK4585","BK0238","603231","BK4597","LU0385154629.USD","LU2211817866.USD","BK4189","ADM","LU1571399168.USD","LU0471298777.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622026949","title":"索宝蛋白(603231.SH):目前在中东市场的销售占比极低","url":"https://stock-news.laohu8.com/highlight/detail?id=2622026949","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622026949?lang=zh_cn&edition=full","pubTime":"2026-03-25 16:47","pubTimestamp":1774428421,"startTime":"0","endTime":"0","summary":"格隆汇3月25日丨索宝蛋白(603231.SH)在投资者互动平台表示,公司目前在中东市场的销售占比极低,出口业务受到运输等负面影响情况极少;目前也未受益于海外订单产能转移至公司的情况,上述事项对公司整体影响较小。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260325/32097487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["603231","BK0238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621084549","title":"股市必读:索宝蛋白(603231)3月23日收盘跌6.46%,主力净流出216.71万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621084549","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621084549?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:15","pubTimestamp":1774296914,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,索宝蛋白报收于16.21元,下跌6.46%,换手率3.54%,成交量3.76万手,成交额6240.55万元。当日关注点来自交易信息汇总:索宝蛋白股价连续3日下跌,3月23日收盘报16.21元,跌6.46%,主力资金当日净流出216.71万元。资金流向3月23日主力资金净流出216.71万元,占总成交额3.47%;游资资金净流出20.53万元,占总成交额0.33%;散户资金净流入237.24万元,占总成交额3.8%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400004898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619456439","title":"索宝蛋白(603231)披露股东减持股份计划公告,3月16日股价下跌0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619456439","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619456439?lang=zh_cn&edition=full","pubTime":"2026-03-16 17:22","pubTimestamp":1773652920,"startTime":"0","endTime":"0","summary":"截至2026年3月16日收盘,索宝蛋白报收于18.68元,较前一交易日下跌0.21%,最新总市值为35.76亿元。近日,索宝蛋白披露《减持股份计划公告》。公告显示,截至公告披露日,股东邦吉(上海)管理有限公司持有公司股份1,445,215股,占总股本的0.75%,股份来源于IPO前取得,已于2024年12月16日上市流通。本次减持计划与此前承诺一致,不会导致公司控制权变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600023940.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619120222","title":"每周股票复盘:索宝蛋白(603231)股东拟减持不超0.75%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2619120222","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619120222?lang=zh_cn&edition=full","pubTime":"2026-03-15 02:20","pubTimestamp":1773512424,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘,索宝蛋白报收于18.72元,较上周的18.51元上涨1.13%。本周,索宝蛋白3月13日盘中最高价报19.1元。本周关注点公司公告汇总:股东邦吉(上海)拟减持不超1,445,215股,即不超总股本的0.75%公司公告汇总减持股份计划公告截至公告披露日,宁波索宝蛋白科技股份有限公司股东邦吉(上海)管理有限公司持有公司股份1,445,215股,占总股本的0.75%,股份来源于IPO前取得,已于2024年12月16日上市流通。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619192627","title":"索宝蛋白最新公告:股东上海邦吉拟减持不超0.75%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2619192627","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619192627?lang=zh_cn&edition=full","pubTime":"2026-03-13 20:19","pubTimestamp":1773404368,"startTime":"0","endTime":"0","summary":"索宝蛋白(603231.SH)公告称,特定股东邦吉(上海)管理有限公司(简称“上海邦吉”)因自身资金需求,拟通过集中竞价方式减持公司股份不超过1,445,215股,即不超过公司总股本的0.75%;减持期间为2026年4月7日至2026年7月6日;所减股份来源于IPO前取得。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300037219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617663328","title":"每周股票复盘:索宝蛋白(603231)现12笔大宗交易机构净买入2522.34万","url":"https://stock-news.laohu8.com/highlight/detail?id=2617663328","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617663328?lang=zh_cn&edition=full","pubTime":"2026-03-08 02:59","pubTimestamp":1772909948,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘,索宝蛋白报收于18.51元,较上周的19.22元下跌3.69%。本周,索宝蛋白3月2日盘中最高价报19.15元。交易信息汇总3月2日索宝蛋白发生12笔大宗交易,机构净买入2522.34万元。公司公告汇总宁波索宝蛋白科技股份有限公司持股5%以上股东济南复星及其一致行动人宁波复星因减持计划期限届满,合计减持公司股份5,380,400股,减持比例2.81%。其中2026年2月26日至3月2日通过大宗交易方式合计减持2,458,000股,合计持股比例由12.55%降至11.26%,触及1%整数倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800001013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231","BK0238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616342649","title":"3月3日索宝蛋白发布公告,股东减持245.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2616342649","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616342649?lang=zh_cn&edition=full","pubTime":"2026-03-03 20:01","pubTimestamp":1772539278,"startTime":"0","endTime":"0","summary":"证券之星消息,3月3日索宝蛋白发布公告《索宝蛋白:关于持股5%以上股东权益变动触及1%刻度暨减持股份结果公告》,其股东济南财金复星惟实股权投资基金合伙企业、上海复星创富投资管理股份有限公司-宁波梅山保税港区复星惟盈股权投资基金合伙企业于2026年2月26日至2026年3月2日间合计减持245.8万股,占公司目前总股本的1.2838%,变动期间该股股价下跌2.61%,截止3月2日收盘报18.68元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300040051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616005876","title":"股市必读:2月27日索宝蛋白现6笔大宗交易 机构净买入663万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616005876","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616005876?lang=zh_cn&edition=full","pubTime":"2026-03-02 03:30","pubTimestamp":1772393434,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,索宝蛋白报收于19.22元,上涨0.05%,换手率1.48%,成交量1.57万手,成交额3020.66万元。交易信息汇总资金流向2月27日主力资金净流出191.98万元,占总成交额6.36%;游资资金净流出227.15万元,占总成交额7.52%;散户资金净流入419.13万元,占总成交额13.88%。大宗交易2月27日索宝蛋白发生6笔大宗交易,机构净买入663万元。减持后,双方合计持股比例由13.92%下降至12.55%,触及1%的整数倍变动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200001582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231","BK0238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616484597","title":"每周股票复盘:索宝蛋白(603231)现大宗交易机构净买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2616484597","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616484597?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:57","pubTimestamp":1772305028,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,索宝蛋白报收于19.22元,较上周的18.71元上涨2.73%。本周关注点来自交易信息汇总:2月27日索宝蛋白现6笔大宗交易,机构净买入663万元。2月25日索宝蛋白现5笔大宗交易,机构净买入1085.48万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100001098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614014882","title":"2月26日索宝蛋白发布公告,股东减持262.44万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2614014882","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614014882?lang=zh_cn&edition=full","pubTime":"2026-02-26 18:01","pubTimestamp":1772100082,"startTime":"0","endTime":"0","summary":"证券之星消息,2月26日索宝蛋白发布公告《索宝蛋白:关于持股5%以上股东权益变动触及1%刻度的提示性公告》,其股东济南财金复星惟实股权投资基金合伙企业、上海复星创富投资管理股份有限公司-宁波梅山保税港区复星惟盈股权投资基金合伙企业于2025年12月8日至2026年2月25日间合计减持262.44万股,占公司目前总股本的1.3708%,变动期间该股股价下跌1.24%,截止2月25日收盘报19.18元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600029490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614078897","title":"2月25日索宝蛋白现5笔大宗交易 机构净买入1085.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614078897","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614078897?lang=zh_cn&edition=full","pubTime":"2026-02-25 17:29","pubTimestamp":1772011751,"startTime":"0","endTime":"0","summary":"证券之星消息,2月25日索宝蛋白发生大宗交易,交易数据如下:近三个月该股共发生5笔大宗交易,合计成交1.0万手,折价成交5笔。该股近期无解禁股上市。截至2026年2月25日收盘,索宝蛋白报收于19.18元,上涨0.63%,换手率2.79%,成交量2.97万手,成交额5708.38万元。该股近半年内有股东持股变动,合计净减持29.8万股,股东增减持明细如下表:该股最近90天内共有2家机构给出评级,买入评级1家,增持评级1家;过去90天内机构目标均价为24.71。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500028309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0238","603231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610946125","title":"索宝蛋白跌5.22% 2023年上市超募4.2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610946125","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610946125?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:24","pubTimestamp":1770888259,"startTime":"0","endTime":"0","summary":"中国经济网北京2月12日讯 索宝蛋白 今日收报18.70元,跌幅5.22%。 索宝蛋白首次公开发行募集资金总额101,904.16万元,募集资金净额97,945.57万元。索宝蛋白最终募集资金净额比原计划多42,487.31万元。 索宝蛋白公开发行新股的发行费用合计3,958.59万元(不含税),其中承销及保荐费用2,735.85万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260212/32015294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["603231","BK0238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609254975","title":"每周股票复盘:索宝蛋白(603231)每股派现0.07元(含税)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609254975","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609254975?lang=zh_cn&edition=full","pubTime":"2026-02-08 02:10","pubTimestamp":1770487826,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘,索宝蛋白报收于19.96元,较上周的19.92元上涨0.2%。本周,索宝蛋白2月5日盘中最高价报20.3元。本周关注点公司公告汇总:索宝蛋白每股派发现金红利0.07元(含税),股权登记日为2026年2月11日。公司公告汇总宁波索宝蛋白科技股份有限公司2025年前三季度权益分派实施公告:每股派发现金红利0.07元(含税),股权登记日为2026年2月11日,除权(息)日为2026年2月12日,现金红利发放日为2026年2月12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603231","BK0238"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609237733","title":"索宝蛋白(603231.SH)2025年前三季度权益分派:每股派利0.07元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609237733","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609237733?lang=zh_cn&edition=full","pubTime":"2026-02-05 20:17","pubTimestamp":1770293821,"startTime":"0","endTime":"0","summary":"格隆汇2月5日丨索宝蛋白(603231.SH)公布2025年前三季度权益分派实施公告,本次利润分配以方案实施前的公司总股本191,459,105股为基数,每股派发现金红利0.07元(含税),共计派发现金红利13,402,137.35元。\r\n\r\n 本次权益分派股权登记日为:2026年2月11日,除权除息日为:2026年2月12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260205/32001598.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["603231","BK0238"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777312970843,"stockEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.033},{"period":"3month","weight":-0.0908},{"period":"6month","weight":-0.0954},{"period":"1year","weight":0.0972},{"period":"ytd","weight":-0.0233}],"compareEarnings":[{"period":"1week","weight":0.001},{"period":"1month","weight":0.0441},{"period":"3month","weight":-0.0129},{"period":"6month","weight":0.0174},{"period":"1year","weight":0.2401},{"period":"ytd","weight":0.0296}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"宁波索宝蛋白科技股份有限公司","boardCode":"AI0013","boardName":"农副食品加工业","stockholders":"17076人(较上一季度增加1.26%)","perCapita":"6223股","listingDate":"2023-12-15","address":"浙江省宁波市北仑区保税区兴业大道12号","registeredCapital":"19145万元","survey":" 宁波索宝蛋白科技股份有限公司的主营业务是大豆蛋白系列产品的研发、生产和销售。公司的主要产品是大豆分离蛋白、大豆浓缩蛋白、组织化蛋白、非转基因大豆油、大豆膳食纤维。2024年,子公司生物科技被国家工信部认定为国家级绿色工厂,实现企业绿色产业化健康发展。2025年,生物科技荣获“山东省农业行业领军企业”、“山东省制造业单项冠军企业”“高新技术企业”等荣誉,非转基因大豆油获得“鲁链优品”认定。","listedPrice":21.29},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"索宝蛋白(603231)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供索宝蛋白(603231)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"索宝蛋白,603231,索宝蛋白股票,索宝蛋白股票老虎,索宝蛋白股票老虎国际,索宝蛋白行情,索宝蛋白股票行情,索宝蛋白股价,索宝蛋白股市,索宝蛋白股票价格,索宝蛋白股票交易,索宝蛋白股票购买,索宝蛋白股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"索宝蛋白(603231)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供索宝蛋白(603231)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}